Xinfengming Group Past Earnings Performance
Past criteria checks 3/6
Xinfengming Group's earnings have been declining at an average annual rate of -10.3%, while the Chemicals industry saw earnings growing at 4.9% annually. Revenues have been growing at an average rate of 14.8% per year. Xinfengming Group's return on equity is 5.6%, and it has net margins of 1.4%.
Key information
-10.3%
Earnings growth rate
-14.6%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 14.8% |
| Return on equity | 5.6% |
| Net Margin | 1.4% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Xinfengming Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 66,466 | 945 | 832 | 1,237 |
| 30 Jun 24 | 64,558 | 1,212 | 828 | 1,294 |
| 31 Mar 24 | 63,411 | 1,172 | 811 | 1,255 |
| 31 Dec 23 | 61,469 | 1,086 | 778 | 1,198 |
| 30 Sep 23 | 57,044 | 397 | 765 | 1,166 |
| 30 Jun 23 | 55,255 | -120 | 733 | 1,101 |
| 31 Mar 23 | 52,694 | -301 | 732 | 1,086 |
| 31 Dec 22 | 50,787 | -206 | 726 | 1,078 |
| 30 Sep 22 | 46,144 | 604 | 719 | 1,015 |
| 30 Jun 22 | 44,804 | 1,324 | 686 | 978 |
| 31 Mar 22 | 44,556 | 2,041 | 629 | 942 |
| 31 Dec 21 | 44,770 | 2,254 | 584 | 915 |
| 30 Sep 21 | 50,496 | 2,278 | 539 | 881 |
| 30 Jun 21 | 47,100 | 1,727 | 480 | 765 |
| 31 Mar 21 | 42,736 | 1,042 | 435 | 659 |
| 31 Dec 20 | 36,984 | 603 | 428 | 602 |
| 30 Sep 20 | 32,636 | 507 | 423 | 593 |
| 30 Jun 20 | 31,384 | 965 | 430 | 601 |
| 31 Mar 20 | 31,554 | 1,145 | 448 | 665 |
| 31 Dec 19 | 34,148 | 1,353 | 430 | 684 |
| 30 Sep 19 | 33,651 | 1,073 | 400 | 722 |
| 30 Jun 19 | 34,581 | 1,199 | 376 | 769 |
| 31 Mar 19 | 34,590 | 1,428 | 354 | 701 |
| 01 Jan 19 | 32,659 | 1,423 | 317 | 645 |
| 30 Sep 18 | 29,676 | 2,021 | 293 | 604 |
| 30 Jun 18 | 26,592 | 1,782 | 98 | 734 |
| 31 Mar 18 | 24,044 | 1,532 | 214 | 594 |
| 31 Dec 17 | 22,963 | 1,497 | 247 | 518 |
| 30 Sep 17 | 22,095 | 1,329 | 312 | 342 |
| 30 Jun 17 | 20,546 | 1,124 | 545 | 0 |
| 31 Mar 17 | 18,845 | 879 | 454 | 0 |
| 31 Dec 16 | 17,477 | 732 | 436 | 0 |
| 30 Sep 16 | 16,096 | 309 | 414 | 0 |
| 30 Jun 16 | 15,583 | 145 | 389 | 0 |
| 31 Mar 16 | 15,030 | 193 | 363 | 0 |
| 31 Dec 15 | 14,640 | 304 | 342 | 0 |
| 30 Sep 15 | 14,552 | 475 | 275 | 0 |
| 30 Jun 15 | 14,601 | 490 | 286 | 0 |
| 31 Mar 15 | 14,623 | 455 | 254 | 0 |
| 31 Dec 14 | 14,755 | 291 | 253 | 0 |
| 30 Sep 14 | 14,500 | 104 | 267 | 0 |
| 30 Jun 14 | 13,955 | 102 | 191 | 0 |
| 31 Mar 14 | 13,493 | 62 | 251 | 0 |
| 31 Dec 13 | 12,829 | 36 | 236 | 0 |
Quality Earnings: 603225 has a large one-off gain of CN¥188.5M impacting its last 12 months of financial results to 30th September, 2024.
Growing Profit Margin: 603225's current net profit margins (1.4%) are higher than last year (0.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 603225's earnings have declined by 10.3% per year over the past 5 years.
Accelerating Growth: 603225's earnings growth over the past year (138%) exceeds its 5-year average (-10.3% per year).
Earnings vs Industry: 603225 earnings growth over the past year (138%) exceeded the Chemicals industry -5.3%.
Return on Equity
High ROE: 603225's Return on Equity (5.6%) is considered low.